Nisa Investment Advisors, LLC Alkermes Plc. Transaction History

Nisa Investment Advisors, LLC

  • $25.4 Billion
  • Q3 2025

A detailed history of Nisa Investment Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 8,587 shares of ALKS stock, worth $249,366. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,587
Previous 39,472 78.25%
Holding current value
$249,366
Previous $1.13 Million 77.24%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025
SELL
$26.13 - $30.46 $807,025 - $940,757
-30,885 Reduced 78.25%
8,587 $257,000
Q2 2025

Jul 31, 2025
BUY
$26.59 - $32.65 $3,722 - $4,571
140 Added 0.36%
39,472 $1.13 Million
Q1 2025

Apr 30, 2025
SELL
$28.08 - $36.0 $1.52 Million - $1.95 Million
-54,200 Reduced 57.95%
39,332 $1.3 Million
Q4 2024

Jan 17, 2025
BUY
$25.7 - $31.46 $60,986 - $74,654
2,373 Added 2.6%
93,532 $2.69 Million
Q3 2024

Oct 24, 2024
BUY
$23.01 - $28.55 $32,927 - $40,855
1,431 Added 1.59%
91,159 $2.55 Million
Q2 2024

Jul 19, 2024
BUY
$23.21 - $27.24 $4,038 - $4,739
174 Added 0.19%
89,728 $2.16 Million
Q1 2024

May 01, 2024
BUY
$26.4 - $32.56 $20,829 - $25,689
789 Added 0.89%
89,554 $2.42 Million
Q4 2023

Jan 25, 2024
SELL
$23.37 - $28.68 $60,762 - $74,568
-2,600 Reduced 2.85%
88,765 $2.46 Million
Q2 2023

Aug 11, 2023
SELL
$28.34 - $33.63 $5,101 - $6,053
-180 Reduced 0.2%
91,365 $2.86 Million
Q1 2023

May 02, 2023
SELL
$25.31 - $29.02 $38,901 - $44,603
-1,537 Reduced 1.65%
91,545 $2.58 Million
Q3 2022

Nov 07, 2022
BUY
$22.0 - $31.87 $1.87 Million - $2.71 Million
85,112 Added 1067.9%
93,082 $2.08 Million
Q2 2022

Aug 03, 2022
BUY
$26.4 - $30.54 $9,768 - $11,299
370 Added 4.87%
7,970 $237,000
Q1 2022

Apr 29, 2022
SELL
$23.07 - $27.99 $221,149 - $268,312
-9,586 Reduced 55.78%
7,600 $200,000
Q4 2021

Feb 03, 2022
SELL
$21.47 - $32.08 $43,111 - $64,416
-2,008 Reduced 10.46%
17,186 $438,000
Q3 2021

Oct 18, 2021
BUY
$23.37 - $32.13 $365,600 - $502,641
15,644 Added 440.68%
19,194 $592,000
Q2 2021

Aug 06, 2021
SELL
$18.78 - $25.15 $85,449 - $114,432
-4,550 Reduced 56.17%
3,550 $87,000
Q4 2020

Jan 25, 2021
SELL
$15.39 - $22.1 $124,982 - $179,474
-8,121 Reduced 50.06%
8,100 $162,000
Q3 2020

Oct 20, 2020
SELL
$16.16 - $20.66 $130,184 - $166,436
-8,056 Reduced 33.18%
16,221 $269,000
Q2 2020

Jul 27, 2020
BUY
$13.31 - $19.41 $194,632 - $283,832
14,623 Added 151.47%
24,277 $471,000
Q1 2020

Apr 17, 2020
BUY
$13.06 - $21.24 $53,546 - $87,084
4,100 Added 73.82%
9,654 $139,000
Q4 2019

Jan 17, 2020
SELL
$17.29 - $21.74 $128,222 - $161,223
-7,416 Reduced 57.18%
5,554 $113,000
Q3 2019

Oct 17, 2019
BUY
$19.51 - $24.28 $214,024 - $266,351
10,970 Added 548.5%
12,970 $253,000
Q2 2019

Jul 12, 2019
SELL
$21.47 - $37.33 $83,518 - $145,213
-3,890 Reduced 66.04%
2,000 $45,000
Q4 2018

Jan 17, 2019
SELL
$27.94 - $44.61 $111,760 - $178,440
-4,000 Reduced 40.44%
5,890 $174,000
Q3 2018

Oct 16, 2018
SELL
$38.6 - $46.12 $66,006 - $78,865
-1,710 Reduced 14.74%
9,890 $420,000
Q2 2018

Jul 19, 2018
SELL
$40.56 - $51.36 $1.41 Million - $1.79 Million
-34,800 Reduced 75.0%
11,600 $477,000
Q1 2018

Apr 10, 2018
BUY
$53.61 - $67.26 $268,050 - $336,300
5,000 Added 12.08%
46,400 $2.68 Million
Q4 2017

Jan 12, 2018
BUY
$47.69 - $55.39 $114,456 - $132,936
2,400 Added 6.15%
41,400 $2.27 Million
Q3 2017

Oct 13, 2017
BUY
$49.16 - $54.45 $1.92 Million - $2.12 Million
39,000
39,000 $1.98 Million

Others Institutions Holding ALKS

# of Institutions
402
Shares Held
176M
Call Options Held
901K
Put Options Held
400K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.77B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email